Leo Mansell, Rufus O’Reilly, Luigi Vennetucci, Matthew J. Daniels
{"title":"区域性遗传性心脏病服务的肥厚性心肌病队列分析,重点关注新型心肌肌球蛋白抑制剂治疗的资格","authors":"Leo Mansell, Rufus O’Reilly, Luigi Vennetucci, Matthew J. Daniels","doi":"10.1136/heartjnl-2022-bcs.17","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":152114,"journal":{"name":"ACHD/Valve Disease/Pericardial Disease/Cardiomyopathy","volume":"61 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"17 Analysis of a hypertrophic cardiomyopathy cohort in a regional inherited cardiac conditions service, with a focus on eligibility for novel cardiac myosin inhibitor therapies\",\"authors\":\"Leo Mansell, Rufus O’Reilly, Luigi Vennetucci, Matthew J. Daniels\",\"doi\":\"10.1136/heartjnl-2022-bcs.17\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":152114,\"journal\":{\"name\":\"ACHD/Valve Disease/Pericardial Disease/Cardiomyopathy\",\"volume\":\"61 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ACHD/Valve Disease/Pericardial Disease/Cardiomyopathy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/heartjnl-2022-bcs.17\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACHD/Valve Disease/Pericardial Disease/Cardiomyopathy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/heartjnl-2022-bcs.17","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
17 Analysis of a hypertrophic cardiomyopathy cohort in a regional inherited cardiac conditions service, with a focus on eligibility for novel cardiac myosin inhibitor therapies